APPLICATION
NDA215400
TYPE
NDA
ORIGINAL APPROVAL
2025-05-14
LATEST ACTION
2025-05-14
ROUTE
SUBCUTANEOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
BREKIYA (AUTOINJECTOR) · ReferencePrescription
DIHYDROERGOTAMINE MESYLATE 1MG/ML · SOLUTION · SUBCUTANEOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.